Bioavailability of spiramycin and lincomycin after oral administration to fed and fasted pigs-Reference-Cited by-同舟云学术

Bioavailability of spiramycin and lincomycin after oral administration to fed and fasted pigs

Published:1998-08 Issue:4 Volume:21 Page:251-256
ISSN:0140-7783
Container-title:Journal of Veterinary Pharmacology and Therapeutics
language:en
Short-container-title:Journal of Veterinary Pharmacology and Therapeutics

Author:

Nielsen P.¹,Gyrd‐Hansen N.¹

Affiliation:

1. Department of Pharmacology and Pathobiology, Royal Veterinary and Agricultural University, 13 Bülowsvej, 1870 Frederiksberg C, Denmark

Publisher

Wiley

Subject

General Veterinary,Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2885.1998.00131.x

Reference23 articles.

1. Clinical Pharmacokinetics in Veterinary Medicine

2. Noncompartmental Determination of the Steady‐State Volume of Distribution

3. Comparative pharmacokinetics of antibiotics in newborn calves: Chloramphenicol, lincomycin, and tylosin.;Burrows, G.E.,;American Journal of Veterinary Research,1983

4. Chloramphenicol, lincomycin and oxytetracycline disposition in calves with experimental pneumonic pasteurellosis

5. Spiramycin concentrations in plasma and genital-tract secretions after intravenous administration in the ewe*

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral bioavailability and egg drug residue of lincomycin in laying hens after different treatment;Poultry Science;2024-01

2. Susceptibility of Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis Isolated from Pigs in Hungary between 2018 and 2021;Antibiotics;2023-08-08

3. Antimicrobial susceptibility profiles of Mycoplasma hyorhinis strains isolated from five European countries between 2019 and 2021;PLOS ONE;2022-08-11

4. Antibiotic Resistance: One Health One World Outlook;Frontiers in Cellular and Infection Microbiology;2021-11-25

5. Maximum levels of cross‐contamination for 24 antimicrobial active substances in non‐target feed. Part 5: Lincosamides: lincomycin;EFSA Journal;2021-10